nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of variables of plasmid transformation of a bacterial vaccine: studies on recombinant BCG
|
Lugosi, Laszlo |
|
1990 |
8 |
2 |
p. 145-149 5 p. |
artikel |
2 |
Anticipating and assessing health care technology. Volume 6: Application of the new biotechnology. The case of vaccines
|
Bos, Cees A. |
|
1990 |
8 |
2 |
p. 173-174 2 p. |
artikel |
3 |
Calendar
|
|
|
1990 |
8 |
2 |
p. 176- 1 p. |
artikel |
4 |
Cell wall structures which may be important for successful immunization with Salmonella-Shigella hybrid vaccines
|
Schultz, C.L. |
|
1990 |
8 |
2 |
p. 115-120 6 p. |
artikel |
5 |
Characterization of the adjuvant-free serological response to protein antigens coupled to antibodies specific for class II MHC determinants
|
Carayanniotis, George |
|
1990 |
8 |
2 |
p. 137-144 8 p. |
artikel |
6 |
Dangers of immunosuppressive treatments in postexposure rabies prophylaxis
|
Fescharek, R. |
|
1990 |
8 |
2 |
p. 172-173 2 p. |
artikel |
7 |
Development and persistence of antibody in a high risk institutionalized population given plasma-derived hepatitis B vaccine
|
West, David J. |
|
1990 |
8 |
2 |
p. 111-114 4 p. |
artikel |
8 |
Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection
|
Masihi, K.N. |
|
1990 |
8 |
2 |
p. 159-163 5 p. |
artikel |
9 |
Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus
|
Collins, Peter L. |
|
1990 |
8 |
2 |
p. 164-168 5 p. |
artikel |
10 |
Fowl-pox virus promoter used in pox virus expression vector systems for the delivery of vaccine antigens, preferably to poultry; DNA sequence
|
|
|
1990 |
8 |
2 |
p. 170- 1 p. |
artikel |
11 |
Gene expression system especially for rotavirus VP7 protein using a foreign signal peptide gene and an optional transmembrane anchor domain; vaccinia virus, adeno virus vector; application in vaccine
|
|
|
1990 |
8 |
2 |
p. 171- 1 p. |
artikel |
12 |
HIV virus gag-env fusion protein with potential application as a vaccine
|
|
|
1990 |
8 |
2 |
p. 169- 1 p. |
artikel |
13 |
Immunogenic glycoprotein of human cytomegalovirus envelope used in vaccine or for producing antibody to diagnose or treat infection
|
|
|
1990 |
8 |
2 |
p. 170- 1 p. |
artikel |
14 |
Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients
|
Talwar, G.P. |
|
1990 |
8 |
2 |
p. 121-129 9 p. |
artikel |
15 |
Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers
|
Gonczol, Eva |
|
1990 |
8 |
2 |
p. 130-136 7 p. |
artikel |
16 |
Japanese Association for Animal Cell Technology
|
Spier, R.E. |
|
1990 |
8 |
2 |
p. 174-175 2 p. |
artikel |
17 |
Modified, attenuated RNA virus strains with reduced replication rate obtained by mutagenizing RNA virus cDNA to change base pairing; polio virus recombinant vaccine production
|
|
|
1990 |
8 |
2 |
p. 170- 1 p. |
artikel |
18 |
New antiviral strategies
|
Phillpotts, Robert |
|
1990 |
8 |
2 |
p. 173- 1 p. |
artikel |
19 |
New isolated and synthetic T lymphocyte bacterial epitopes for use as carriers for antigens, producing immunogenic conjugates for vaccines
|
|
|
1990 |
8 |
2 |
p. 171- 1 p. |
artikel |
20 |
New 28 kDa phosphoprotein from human cytomeglovirus recombinant vaccine construction and DNA probe for diagnosis; pp28 gene cloning and expression in Escherichia coli; DNA sequence
|
|
|
1990 |
8 |
2 |
p. 169- 1 p. |
artikel |
21 |
New recombinant circumsporozoite antigen from Plasmodium falciparum for use in vaccine, diagnosis, etc., efficiently expressed in baculovirus-insect system
|
|
|
1990 |
8 |
2 |
p. 170- 1 p. |
artikel |
22 |
New recombinant polypeptide from gB gene of cytomegalovirus; new expression vector, DNA sequence; useful in vaccine, diagnosis, therapy
|
|
|
1990 |
8 |
2 |
p. 171- 1 p. |
artikel |
23 |
Pertussis vaccine controversy
|
Gupta, R.K. |
|
1990 |
8 |
2 |
p. 172- 1 p. |
artikel |
24 |
Production of rota virus in yeast for vaccine production using a Saccharomyces cerevisiae expression vector to produce glycosylated human WA rota virus surface antigen VP7; recombinant vaccine production
|
|
|
1990 |
8 |
2 |
p. 169- 1 p. |
artikel |
25 |
Protection of adult rabbits and monkeys from lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y
|
Ahmed, Zia U. |
|
1990 |
8 |
2 |
p. 153-158 6 p. |
artikel |
26 |
Protective effect of heterologous Gram-positive vaccine against lethal upper respiratory tract infection with type M50 group A streptococci in mice
|
Stjernquist-Desatnik, A. |
|
1990 |
8 |
2 |
p. 150-152 3 p. |
artikel |
27 |
Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children
|
Eskola, Juhani |
|
1990 |
8 |
2 |
p. 107-110 4 p. |
artikel |
28 |
Recombinant DNA coding for Eimeria tenella immunogen useful in production of recombinant vaccine for protecting fowl against coccidiosis; DNA sequence
|
|
|
1990 |
8 |
2 |
p. 171- 1 p. |
artikel |
29 |
Recombinant hepatitis B surface antigen and recombinant vaccine, recombinant DNA sequence and transformed Saccharomyces cerevisiae
|
|
|
1990 |
8 |
2 |
p. 171- 1 p. |
artikel |
30 |
Recombinant Marek-disease virus encoding a foreign gene; turkey herpes virus expression in bird cell culture to produce cheap, live recombinant vaccine against virus; DNA sequence
|
|
|
1990 |
8 |
2 |
p. 171- 1 p. |
artikel |
31 |
Recombinant vaccine against rinderpest virus comprises a recombinant vaccinia virus containing an antigenic protein of rinderpest virus and a viral promoter
|
|
|
1990 |
8 |
2 |
p. 171- 1 p. |
artikel |
32 |
Rhesus rotavirus VP3 or VP7 polypeptides which stimulate production of neutralizing antibodies for protection against rotavirus infection
|
|
|
1990 |
8 |
2 |
p. 170- 1 p. |
artikel |
33 |
Rhoptry membrane antigen of Plasmodium falciparum used for antibody production and in malaria vaccine, diagnosis and therapy
|
|
|
1990 |
8 |
2 |
p. 169- 1 p. |
artikel |
34 |
Testing of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine for freedom from abnormal toxicity
|
Bhandari, S.K. |
|
1990 |
8 |
2 |
p. 105-106 2 p. |
artikel |
35 |
The last 10 years and the next
|
|
|
1990 |
8 |
2 |
p. 99-100 2 p. |
artikel |
36 |
Tumour-specific vaccine production by incubating irradiated tumour cells with Newcastle-disease virus
|
|
|
1990 |
8 |
2 |
p. 170- 1 p. |
artikel |
37 |
Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies
|
Brochier, B. |
|
1990 |
8 |
2 |
p. 101-104 4 p. |
artikel |
38 |
Vaccinia virus vector construction for recombinant vaccine preparation; plasmid construction with pox virus-A inclusion body gene promoter and 3′-untranslated region
|
|
|
1990 |
8 |
2 |
p. 169- 1 p. |
artikel |
39 |
Vol. 35: Progress in Medical Virology
|
Spier, R.E. |
|
1990 |
8 |
2 |
p. 174- 1 p. |
artikel |